Results 1 -
10
of
175
for
pembrolizumab
- FDA has approved the immunotherapy drug pembrolizumab (Keytruda®) for use in some patients with advanced gastric (stomach) cancer that is PD-L1 positive.
- Find what's new in melanoma and other skin cancers research, including current progress in targeted therapies, immune checkpoint inhibitors, and adoptive ...
- ... clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced ...
- Targeted Therapy - Immunotherapy Combinations Effective for Advanced Kidney Cancer
(National Cancer Institute)
Kidney Cancer/Statistics and Research ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... For patients with advanced kidney cancer, ... - This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer. The list includes generic names and brand names. The drug ...
- Lung Cancer/Diagnosis and Tests ... Lung Cancer ... Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted ...
- Lung Cancer/Treatments and Therapies ... Lung Cancer ... Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted ...
- Lung Cancer/Start Here ... Lung Cancer ... Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, ...
- Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... Learn how bladder cancer is treated, based on the stage of the cancer. ... National Cancer Institute ... From ...
- Learn what's new in lung cancer research through recent findings from studies that used immunotherapy and targeted therapies to treat lung cancer. Find ...